Modulation of bovine mammary neutrophil function during the periparturient period following in vitro exposure to recombinant bovine interferon gamma.
Effects of recombinant bovine interferon (rBoIFN) gamma on mammary gland neutrophil activity during the periparturient period were studied. Bovine mammary gland neutrophils were isolated and incubated in mammary gland secretions obtained from Holstein-Friesian cattle during the last 2 weeks of gestation. Cell functions were evaluated following treatment with 10 U, 100 U, and 1000 U of rBoIFN-gamma. Bacterial phagocytosis, bactericidal activity and chemiluminescence were significantly lower for neutrophils incubated in mammary gland secretions when compared with control neutrophils incubated in Hank's balanced salt solution. Treatment of mammary neutrophils with rBoIFN-gamma reversed the suppressive effects of mammary secretions resulting in higher chemiluminescent activity and significantly more bacterial phagocytosis and bactericidal activity when compared with untreated controls. Results from these preliminary in vitro data suggest that rBoIFN-gamma therapy may modulate mammary gland neutrophil functions in vivo and possibly facilitate the rapid clearance of mastitis-causing pathogens mammary glands during the periparturient period.
Sordillo
L M
LM
Veterinary Infectious Disease Organization, University of Saskatchewan, Sask, Canada.
Babiuk
L A
LA
D000818:Animals; D002417:Cattle; D005260:Female; D066298:In Vitro Techniques; D007371:Interferon-gamma / Q000494:pharmacology*; D007743:Labor, Obstetric; D008163:Luminescent Measurements; D008213:Lymphocyte Activation / Q000187:drug effects; D008321:Mammary Glands, Animal / Q000166:cytology / Q000276:immunology*; D008892:Milk / Q000276:immunology; D009504:Neutrophils / Q000276:immunology* / Q000648:ultrastructure; D010587:Phagocytosis / Q000187:drug effects; D011247:Pregnancy; D011994:Recombinant Proteins; D013211:Staphylococcus aureus / Q000254:growth & development
D011994:Recombinant Proteins; D007371:Interferon-gamma